Arrowhead Pharmaceuticals Inc (ARWR)
19.63
-0.12
(-0.61%)
USD |
NASDAQ |
Dec 24, 16:00
Arrowhead Pharmaceuticals Free Cash Flow: -604.32M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics Inc | -480.40M |
| Amgen Inc | 6.283B |
| Vertex Pharmaceuticals Inc | -1.352B |
| Avidity Biosciences Inc | -188.51M |
| Harmony Biosciences Holdings Inc | 220.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -137.22M |
| Cash from Investing (Quarterly) | -222.92M |
| Cash from Financing (Quarterly) | 389.09M |
| Free Cash Flow Per Share (Quarterly) | -1.299 |
| Free Cash Flow Yield | -25.69% |